Sunzen Biotech Bhd (0148) — Cash Flow-to-Debt Ratio
Sunzen Biotech Bhd (0148) has a Cash Flow-to-Debt Ratio of 0.22x as of September 2023, meaning its operating cash flow of RM3.58 Million could theoretically repay 0% of its total liabilities (RM16.55 Million) in one year. Check Sunzen Biotech Bhd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sunzen Biotech Bhd Cash Flow-to-Debt Ratio (2016–2023)
Historical debt coverage capacity for Sunzen Biotech Bhd across 8 annual periods. Also explore Sunzen Biotech Bhd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Sunzen Biotech Bhd (2016–2023)
Year-by-year debt coverage analysis for Sunzen Biotech Bhd. For market capitalisation and broader financial context, see Sunzen Biotech Bhd (0148) total market value.
| Year | CF-to-Debt Ratio | Operating CF (MYR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | RM819.39K | RM20.51 Million | ▲ +103.6% |
| 2022 | -1.10x | RM-32.06 Million | RM29.08 Million | ▼ -106.3% |
| 2021 | -0.53x | RM-16.36 Million | RM30.61 Million | ▼ -365.1% |
| 2020 | 0.20x | RM7.20 Million | RM35.73 Million | ▲ +167.5% |
| 2019 | -0.30x | RM-11.05 Million | RM36.96 Million | ▼ -198.6% |
| 2018 | -0.10x | RM-4.07 Million | RM40.63 Million | ▼ -149.0% |
| 2017 | 0.20x | RM4.02 Million | RM19.70 Million | ▲ +615.6% |
| 2016 | 0.03x | RM256.13K | RM8.98 Million | — |